Pluristem Therapeutics Inc (PSTI)

[Scott999]

But that proves nothing when it comes to the question I asked. Is that the ONLY answer, bad trial design. Could it not be the therapy itself? I just don't know how you come to that specific conclusion as opposed to your following statement. "This suggests that it's not necessarily treatment/technology specific". Inconclusive results needing larger data sets Could be very well therapy related, not necessarily poor design.

Was waiting for specific points from the actual design, but you just throw out comments to support your thoughts that management doesn't matter.

What's your thoughts on our IC design with walking distance test being our only measured outcome? Is the single outcome used more often than not these days? What happens if they are inconclusive or not off the charts?